The sale of Vectura Group Ltd. follows PMI's 2021 acquisition of Vectura, which has been instrumental in kick-starting Vectura Fertin Pharma’s development of inhaled therapeutics. Despite the ...

Qualitas Equity Funds SGEIC, S.A. for an initial purchase price of $63 million, with the potential for additional earnout consideration. This acquisition is expected to establish a European presence ...

The company's CEO, Zach Bradford, highlighted the substantial increase in operational capacity over the last seven days, totaling 211.5 MW of new capacity. This represents a remarkable 38% increase, ...

RXO (NYSE: RXO) has finalized the acquisition of Coyote Logistics from UPS for a total of $1.025 billion, propelling the company to become the third-largest provider of brokered transportation ...

VinFast Auto has an average level of shares sold short, at 7.4% of its total share float. The stock's short ratio (also called days to cover) is 4.41. Since 99.48% of the company's shares are owned by ...

Another number to watch is the company's rate of institutional share ownership, which now stands at 91.7%. In conclusion, we believe there is positive market sentiment regarding Atlassian.

Talos Energy Inc. has just released its fifth annual sustainability report for the 2023 calendar year, showcasing the company's dedication to transparency, emissions reduction efforts, and ...

ChargePoint has been a pioneer in EV charging since 2007, offering solutions for the entire EV ecosystem. With a portfolio of software, hardware, and services, ChargePoint has facilitated over 10 ...

Accenture logged a -4.7% change during today's afternoon session, and is now trading at a price of $337.48 per share.

Oracle shares rose 5.1% this morning to a price of $170.33. The stock is still trading within range of its average target price of $174.51, and over the last 52 weeks, it has recorded a 51.0% ...

What Are the Fundamentals Of WM?

SLE affects approximately 430,000 individuals globally, and currently available treatments do not routinely induce treatment-free remission. CLN-978 is a novel CD19 bispecific T cell engager designed ...